Pfizer takes paediatric 25-valent pneumococcal vaccine to Phase III - FirstWord PHARMA
Pfizer takes paediatric 25-valent pneumococcal vaccine to Phase III FirstWord PHARMA
Pfizer takes paediatric 25-valent pneumococcal vaccine to Phase III FirstWord PHARMA
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.